COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA

被引：1
|
作者：
Whillans, F. [1 ]
Kwan, H. [1 ]
Strutton, D. R. [2 ]
Earnshaw, S. R. [3 ]
Farkouh, R. [3 ]
机构：
[1] Wyeth Pharmaceut, Markham, ON, Canada
[2] Wyeth Res, Collegeville, PA USA
[3] RTI Hlth Solut, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75101-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A425 / A425
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    VACCINE, 2011, 29 (38) : 6686 - 6694
  • [2] Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
    Sundaram, Neisha
    Chen, Cynthia
    Yoong, Joanne
    Luvsan, Munkh-Erdene
    Fox, Kimberley
    Sarankhuu, Amarzaya
    La Vincente, Sophie
    Jit, Mark
    VACCINE, 2017, 35 (07) : 1055 - 1063
  • [3] COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN KAZAKHSTAN
    Bektur, C.
    Nurgozhin, T.
    VALUE IN HEALTH, 2015, 18 (03) : A106 - A106
  • [4] Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children
    Ayieko, Philip
    Griffiths, Ulla K.
    Ndiritu, Moses
    Moisi, Jennifer
    Mugoya, Isaac K.
    Kamau, Tatu
    English, Mike
    Scott, J. Anthony G.
    PLOS ONE, 2013, 8 (06):
  • [5] Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Stephanie R Earnshaw
    Cheryl L McDade
    Giovanni Zanotti
    Raymond A Farkouh
    David Strutton
    BMC Infectious Diseases, 12
  • [6] COST-EFFECTIVENESS OF 13-VALENT VERSUS 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USE IN CROATIA NATIONAL VACCINATION PROGRAM
    Tichopad, A.
    Pecen, L.
    Roberts, C. S.
    Uglesic, L.
    Tesovic, G.
    Rogier, K.
    VALUE IN HEALTH, 2014, 17 (07) : A608 - A608
  • [7] The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    van Hoek, Albert Jan
    Choi, Yoon Hong
    Trotter, Caroline
    Miller, Elizabeth
    Jit, Mark
    VACCINE, 2012, 30 (50) : 7205 - 7213
  • [8] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [9] Cost-effectiveness of 2+1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Zanotti, Giovanni
    Farkouh, Raymond A.
    Strutton, David
    BMC INFECTIOUS DISEASES, 2012, 12
  • [10] COST-EFFECTIVENESS OF SWITCHING STRATEGIES FROM A 7-VALENT TO A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
    Claes, C.
    Mittendorf, T.
    Kuchenbecker, U.
    Rose, M.
    Reinert, R. R.
    VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
12345